Classification in von Willebrand Disease: Why Different Forms Behave Differently

Prev
 1 / 20 
Next
Prev
 1 / 20 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • explain why VWD classification is organized around biological mechanisms rather than bleeding severity.
  • distinguish quantitative from qualitative forms of VWD using laboratory patterns.
  • interpret VWF laboratory results in the context of underlying biology rather than isolated numerical values.
  • recognize how specialized laboratory tests and genetic testing contribute to subtype classification.
  • explain why patients with the same subtype may have different bleeding phenotypes.
  • apply VWD classification to guide diagnostic reasoning and management.

Which statement best explains the primary purpose of classifying von Willebrand disease?

a
To predict bleeding severity.
Bleeding severity varies considerably within every subtype.
b
To organize disorders according to their underlying biological mechanisms.
Modern VWD classification organizes disorders according to the biological mechanism responsible for abnormal VWF. This framework explains laboratory findings, guides additional testing, and informs treatment.
c
To determine which patients require prophylaxis.
Treatment decisions depend on bleeding phenotype, clinical setting, and treatment response rather than subtype alone.
d
To estimate future plasma VWF levels.
Plasma VWF levels fluctuate and are not the primary purpose of classification.

Which pair of VWD subtypes are both considered quantitative disorders?

a
Type 1 and Type 3
Type 1 and type 3 VWD are quantitative disorders characterized by reduced amounts of VWF. Type 1 represents partial deficiency, whereas type 3 reflects near-complete absence of VWF.
b
Type 2A and Type 2M
Both are qualitative disorders.
c
Type 2B and Type 2N
Both are qualitative disorders.
d
Type 1C and Type 2M
Type 1C reflects accelerated clearance, whereas type 2M is a qualitative defect.

A patient with type 2B VWD is being considered for desmopressin before a dental extraction. Why is desmopressin generally avoided or used with particular caution in this subtype?

a
It prevents endothelial release of VWF.
Desmopressin stimulates rather than prevents VWF release.
b
It consistently produces inadequate FVIII responses.
FVIII responses are not uniformly inadequate.
c
It accelerates VWF clearance.
Accelerated clearance characterizes type 1C, not type 2B.
d
It may release abnormal VWF that binds platelets and worsens thrombocytopenia.
Desmopressin releases endogenous VWF. In type 2B VWD, the abnormal VWF has increased affinity for platelet GPIb, potentially worsening thrombocytopenia. Although selected patients may respond safely under specialist supervision, desmopressin is generally avoided or used with caution.

A patient has low VWF levels at baseline. After desmopressin, VWF rises appropriately at one hour but falls close to baseline by four hours.

This pattern most strongly suggests:

a
Defective FVIII binding.
Defective FVIII binding characterizes type 2N.
b
Increased VWF synthesis.
Increased synthesis would not explain rapid disappearance.
c
Accelerated VWF clearance.
A brisk early response followed by rapid decline suggests shortened VWF survival, the characteristic physiological feature of the type 1C phenotype.
d
Platelet-type VWD.
Platelet-type VWD is not diagnosed by this response pattern.

Why did the 2021 diagnostic guideline adopt a platelet-dependent activity/VWF:Ag ratio of approximately 0.7 instead of the older cutoff of 0.5?

a
To improve detection of qualitative VWF defects.
The higher threshold improves sensitivity for detecting qualitative VWF defects while reducing false-negative results.
b
To eliminate the need for multimer analysis.
Multimer analysis remains valuable in selected patients.
c
To simplify laboratory reporting.
The recommendation was based on diagnostic performance.
d
To distinguish inherited from acquired VWD.
The ratio does not distinguish inherited from acquired disease.

Genetic testing is most useful in which situation?

a
Confirming every case of type 1 VWD.
Most patients with type 1 VWD do not require genetic confirmation.
b
Measuring bleeding severity.
Genetics does not predict bleeding severity reliably.
c
Distinguishing selected diagnostic mimics and confirming specific subtypes.
Genetic testing is particularly helpful for confirming selected subtypes, distinguishing platelet-type VWD from type 2B VWD, identifying type 2N VWD, and supporting family counseling.
d
Replacing phenotypic laboratory testing.
Phenotypic laboratory testing remains fundamental.

Two siblings inherit the same pathogenic VWF variant. One has frequent mucosal bleeding, whereas the other has only occasional epistaxis.

Which statement best explains this difference?

a
Classification predicts mechanism better than bleeding severity.
Bleeding phenotype is influenced by modifier genes, physiology, medications, anatomy, and the nature of the hemostatic challenge.
b
One sibling probably has acquired VWD.
Variable bleeding does not imply acquired disease.
c
The diagnosis should be reconsidered.
Variable expression is expected.
d
Different bleeding phenotypes exclude an inherited disorder.
Inherited disorders commonly show variable expressivity.

Which statement best describes the role of multimer analysis in suspected type 2 VWD?

a
It independently establishes the subtype in nearly every patient.
Many subtypes share similar multimer patterns.
b
It measures VWF synthesis and clearance.
Multimer analysis does not measure synthesis or clearance.
c
It shows whether high-molecular-weight multimers are preserved or reduced but must be interpreted together with activity assays and other laboratory findings.
Multimer analysis provides important structural information but does not establish subtype by itself. It must be interpreted together with platelet-dependent activity, antigen, FVIII, and, when appropriate, additional specialized testing.
d
It distinguishes inherited from acquired VWD without additional testing.
Additional testing is required.

VWF biology exists along a continuum, and some patients do not fit neatly into a single category.

Why does classification remain clinically useful?

a
It creates exact biological boundaries.
Biological boundaries are not absolute.
b
It identifies the dominant mechanism and guides the next diagnostic or therapeutic step.
Classification simplifies complex biology into clinically useful categories that organize diagnostic reasoning without replacing clinical judgment.
c
It guarantees similar bleeding severity within each subtype.
Bleeding severity varies substantially within every subtype.
d
It eliminates the need to interpret laboratory findings in context.
Laboratory interpretation always requires clinical context.

Which statement best reflects the relationship between laboratory classification and patient care?

a
Once a subtype is assigned, clinical judgment is rarely needed.
Clinical judgment remains essential.
b
Bleeding phenotype can be predicted accurately from subtype alone.
Subtype does not perfectly predict bleeding severity.
c
Laboratory classification is primarily valuable for research studies.
Classification has important day-to-day clinical value.
d
Laboratory classification should be integrated with bleeding history, family history, and clinical context to guide management.
Classification provides a biologic framework, but management decisions also depend on bleeding phenotype, treatment response, family history, comorbidities, and the clinical situation.

Place each statement into the correct category.

Consider a qualitative subtype
Low activity-to-antigen ratio
Mechanism is more informative than severity
Reduced VWF quantity
Defective platelet interaction
Defective FVIII binding
Classification guides the next diagnostic step
Rapid fall after desmopressin
Accelerated VWF clearance
Laboratory findings require context
Loss of high-molecular-weight multimers
Preserved multimers
Mechanism
Laboratory Clue
Clinical Interpretation

Match each finding with the most appropriate interpretation.

Brisk 1-hour response with rapid decline by 4 hours
Discordantly low platelet-dependent activity
Proportionately reduced VWF antigen and activity
Accelerated VWF clearance
Quantitative deficiency
Qualitative VWF defect
Correct! Sorry, Incorrect.

Key takeaways

  • VWD classification is organized around biological mechanism rather than bleeding severity. The goal is to explain how VWF fails, not simply how much a patient bleeds.
  • Quantitative and qualitative defects produce different laboratory patterns. Comparing VWF antigen, platelet-dependent activity, FVIII, and multimer analysis helps localize the underlying mechanism.
  • Classification guides diagnostic reasoning rather than replacing it. Laboratory findings should always be interpreted alongside bleeding history, family history, and the clinical context.
  • Patients within the same subtype may have different bleeding phenotypes. Modifier genes, physiologic factors, medications, and the nature of the hemostatic challenge all influence clinical expression.
  • The most useful classification is the one that leads to the next clinical question. A biologically coherent subtype should explain the phenotype, fit the laboratory findings, and help guide further testing or treatment.

Closing Note

Classification is not the end of diagnostic reasoning. It is the beginning. The most useful subtype is the one that explains the patient’s biology, makes sense of the laboratory findings, and helps the clinician ask the next right question.

Prev
 1 / 20 
Next